Abstract
Long-term Maintenance of Remission with No Dose Escalation After Reinduction with Certolizumab Pegol in Patients with Crohnʼs Disease Exacerbation: 3-year Results from the PRECiSE 4 Study
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
